Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature

10.3389/fimmu.2022.807050

Saved in:

Bibliographic Details
Main Authors:	Tay, Sen Hee, Toh, Michelle Min Xuan, Thian, Yee Liang, Vellayappan, Balamurugan A, Fairhurst, Anna-Marie, Chan, Yiong Huak, Aminkeng, Folefac, Bharwani, Lavina D, Huang, Yiqing, Mak, Anselm, Wong, Alvin Seng Cheong
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Review
Language:	English
Published:	FRONTIERS MEDIA SA 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Immunology immunotherapy immune-related adverse events cytokine release syndrome tocilizumab immune checkpoint inhibitors ADVERSE EVENTS T-CELLS IMMUNOTHERAPY MANAGEMENT TOXICITIES DIAGNOSIS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235037
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!